Owen Mumford

Oxford, United Kingdom Founded: 1952 • Age: 74 yrs Acquired By Embecta
Disposables for drug delivery and capillary blood sampling are manufactured.

About Owen Mumford

Owen Mumford is a Healthcare company based in Oxford (United Kingdom) founded in 1952 by Thomas Owen, John Mumford, and Ivan Owen, and was acquired by Embecta in March 2026. Disposables for drug delivery and capillary blood sampling are manufactured. Owen Mumford has completed 1 acquisition, including Empelvic. Its website owenmumford.com draws about 25 thousand monthly visits. Owen Mumford offers products and services including Unifine® Syringes, Aidaptus® Auto-Injector, Unistik® Devices, and Empelvic. Its focus areas include Life Sciences, Drug Delivery and Safe Syringes. Its legal entity is OWEN MUMFORD LIMITED.

Company details

Owen Mumford was established in 1952 in Oxford, United Kingdom, within the medical devices sector. Operations focus on producing disposables for drug delivery and capillary blood sampling across multiple therapeutic areas. Items such as Unistik, Autopen, Autoject, and Unifine Pentips are developed, alongside proprietary lancets, lancing devices, and safety lancets for blood sampling applications. Distribution occurs globally from the UK base.

  • Headquarters Oxford, United Kingdom
  • Founders Thomas Owen, John Mumford, Ivan Owen
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website owenmumford.com/en
  • Social LinkedIn X Facebook Instagram
  • Acquired by Embecta (Mar 2026)
  • Legal Name Owen Mumford Limited
  • Date of Incorporation 10 May, 1976
  • Jurisdiction WOODSTOCK, OXFORDSHIRE
Key Metrics
  • Latest Funding Round
    $477.22K (USD), Grant

    Dec 2020

  • Investors
    Embecta

    & 1 more

  • Investments & Acquisitions
  • Acquired by
    Embecta

    (Mar 2026)

Products & Services of Owen Mumford

Owen Mumford offers a comprehensive portfolio of products and services, including Unifine® Syringes, Aidaptus® Auto-Injector, Unistik® Devices, and Empelvic.

Unifine® Syringes
Syringes and Needles

Devices for safe medical injections and blood collection

Aidaptus® Auto-Injector
Auto-Injectors

Tool for drug delivery with patient-centric safety features

Unistik® Devices
Point of Care Testing

Lancets for blood sampling and testing procedures

Empelvic
Pelvic Health

Product for pelvic health exercises and support

Funding Insights of Owen Mumford

  • Total Rounds 1
  • Last Round Grant — $477,224
  • First Round $477,224

    (Dec 2020)

  • Investors Count 1

All 1 funding rounds of Owen Mumford with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2020$477,224Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Owen Mumford

Owen Mumford has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Embecta and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Insulin delivery solutions including pen needles and syringes are manufactured.
2022embecta.comParsippany, United States
Premium access

Investor details for Owen Mumford

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Owen Mumford

3 people are tracked at Owen Mumford (3 in leadership).

NameRoleGroup
Thomas Owen
FounderLeadership
John Mumford
Co-FounderLeadership
Ivan Owen
Co-FounderLeadership
Premium access

Complete people profiles for Owen Mumford

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Owen Mumford

Owen Mumford has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Empelvic.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of pelvic floor training device for women
empelvic.dkCopenhagen, Denmark2018Mar 2024••••
Premium access

Complete acquisition details for Owen Mumford

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Owen Mumford

4 dated milestones of Owen Mumford across 74 years, from founding to its latest funding, stage changes and deals.

  1. Founded Owen Mumford is founded.
  2. Funding First funding round of $477K.
  3. Acquisition Acquires Empelvic.
  4. Exit Acquired by Embecta.

Web traffic of Owen Mumford

The website of Owen Mumford (owenmumford.com) receives about 24.8K visits a month and ranks #1,589,531 among all websites worldwide, #2,139 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    24.8K

    ▲ 76.2% vs previous month

  • Unique visitors
    6.7K

    per month

  • Global rank
    #1,589,531

    among all websites

  • Category rank
    #2,139

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Owen Mumford. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
halozyme.com
100%
11.6K#1,481,510View details
uk.linkedin.com
uk.linkedin.com
99%
–
pharmaceutical-technology.com
98%
#316,052View details
unionmedico.com
unionmedico.com
94%
#1,358,313–
superiorhealthcare.com.au
superiorhealthcare.com.au
70%
#2,202,088–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 11 similar websites and full traffic analytics for Owen Mumford

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 11 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Owen Mumford

Premium access

Complete news archive for Owen Mumford

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Owen Mumford

Owen Mumford was founded in 1952 and raised its 1st funding round 68 years after it was founded.

Owen Mumford is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.

Owen Mumford was established in 1952 in Oxford, United Kingdom, within the medical devices sector. Operations focus on producing disposables for drug delivery and capillary blood sampling across multiple therapeutic areas. Items such as Unistik, Autopen, Autoject, and Unifine Pentips are developed, alongside proprietary lancets, lancing devices, and safety lancets for blood sampling applications. Distribution occurs globally from the UK base.

Owen Mumford offers Unifine® Syringes, Aidaptus® Auto-Injector, Unistik® Devices, and Empelvic.

Owen Mumford has made 1 acquisition, including Empelvic.

Owen Mumford has 2 investors. Key investors include Embecta, and European Union.

Owen Mumford operates through Owen Mumford Limited.

Yes. Owen Mumford was acquired by Embecta in March 2026.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available